Hello and Welcome to Patientsville.com, Your Source for all ONCOVIN information. We are dedicated to provide You with ONCOVIN safety information. Learn about ONCOVIN serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ONCOVIN Safety Reports
Total ONCOVIN reports: 3.ONCOVIN FDA safety alerts: No.
Reported hospitalizations: 2.
Take ONCOVIN Side Effects Survey or Share Your ONCOVIN Story. Read More Here.
Consumer or non-health professional from JAPAN reported ONCOVIN problem on Dec 22, 2006. Female patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with ONCOVIN. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen decreased, hyponatraemia. ONCOVIN dosage: unknown. During the same period patient was treated with GLEEVEC. Patient recovered.
ONCOVIN problem was reported by a Consumer or non-health professional from JAPAN on Jan 18, 2007. Female patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with ONCOVIN. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen decreased, hyponatraemia, pancytopenia. ONCOVIN dosage: unknown. During the same period patient was treated with GLEEVEC. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported ONCOVIN problem on Aug 10, 2007. Female patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with ONCOVIN. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen decreased, hyponatraemia, pancytopenia. ONCOVIN dosage: unknown. During the same period patient was treated with GLEEVEC. Patient was hospitalized. Patient recovered.